search
Highlights
    Home  // . //  Oliver Wyman Health //  Slide Show: A New Role for Pharma in Healthcare Value Chain

    Slide Show: A New Role for Pharma in Healthcare Value Chain

    This illustrative example from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

    Table of Contents

      The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

      Is There a New Normal in Commercial Health Insurance?

      The US Department of Labor cited a record-breaking 6.6 million unemployment claims filed last week. What's next?

      State of the Blues: Mega-Mergers, ACA Marketplace & the Future of Local Blue Plans

      Insights into how Blue plans can navigate current market pressures and chart a successful path forward.

      Trumpcare, ACOs, and the Way Forward

      Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.

      Payer + Provider Partnerships (2/3): Build an Integrated Financial Model

      This post is the second in a series of three this week based on a new Oliver Wyman report that explores in-depth how “partnered products”—health insurance products built around a single provider system, multi-specialty group, accountable care organization (ACO), or clinically integrated network(CIN)—are transforming US health insurance.